Vesalio is set to welcome J D McCulloch as its chief financial officer (CFO) for overseeing all financial aspects of the business, and helping drive the company’s financial strategy and business development. According to a press release, he will play a critical role in managing several key areas of the organisation: finance, strategic planning and budgeting, cash management, and risk management.
McCulloch brings Vesalio over 25 years of professional experience spanning investment management, investment banking, business valuation, and corporate finance and accounting, focusing on healthcare and biotechnology over the last decade. He recently served as CFO and head of business development at Dialectic Therapeutics—an oncology-focused biotechnology company. Over his career, McCulloch has served on the board of several businesses, including healthcare companies. He has directed private equity and venture investments with exits exceeding US$4.5 billion, including several successful initial public offerings (IPOs), and has advised on US$10 billion in investment banking transactions.
“Vesalio’s development in the vascular occlusion market in just a brief time has been impressive,” McCulloch commented. “I am excited to join the Vesalio team and help advance the effort of becoming a global thrombectomy company delivering innovative products to improve clinical outcomes and extend patients’ lives.”
McCulloch’s appointment coincides with the establishment of Vesalio’s new headquarters in Plano, USA—a northern suburb of the city of Dallas in the state of Texas. As a growing hub for Fortune 500 companies, top private companies, and clusters of medical device companies, the Dallas area was chosen for its business-friendly environment, highly educated and skilled labour force, low cost of doing business, and world-class transportation infrastructure, according to Vesalio’s recent press release.
“Vesalio’s presence continues to grow globally with a current emphasis on US infrastructure development,” said Vesalio chief executive officer Steve Rybka. “The addition of J D McCulloch as CFO and the relocation of our headquarters to Dallas support the scaling of our operational and commercial activities, both in the USA and internationally.”
